Page 16 - Biomedical Device Technology Science Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biomedical device technology science communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biomedical Device Technology Science Communications Today - Breaking & Trending Today

Zeiss BlueGuard offers improved blue light protection


Zeiss BlueGuard offers improved blue light protection
03 Mar 2021
Blocking potentially damaging wavelengths improves health and concentration.
Healthy viewing: blue light filter
A new product range of lenses from Zeiss aims to offer improved blocking of blue light wavelengths, tackling a recognized health issue for people spending extended periods of time working via screens.
Zeiss BlueGuard lenses incorporate wavelength-blocking material into the lens material itself and block up to 40 percent of incident 400 to 455 nanometer light, according to the company.
The ill-effects of excessive exposure to blue wavelengths from screens and displays has been studied for some time, but the Covid-19 pandemic has exacerbated the problem by compelling many people to incorporate online working with their domestic media consumption. ....

Christian Lappe , Zeiss Blueguard , Guard Lenses , Full Time , Medical Imaging , Health Care Biophotonics , United States , கிறிஸ்துவர் மடியில் , காவலர் லென்ஸ்கள் , முழு நேரம் , மருத்துவ இமேஜிங் , ஒன்றுபட்டது மாநிலங்களில் ,

Pericardial Injection Effective, Less Invasive Way to Get Regenerative Therapies to Heart


Date Time
Pericardial Injection Effective, Less Invasive Way to Get Regenerative Therapies to Heart
Injecting hydrogels containing stem cell or exosome therapeutics directly into the pericardial cavity could be a less invasive, less costly, and more effective means of treating cardiac injury, according to new research from North Carolina State University and the University of North Carolina at Chapel Hill.
Stem cell therapy holds promise as a way to treat cardiac injury, but delivering the therapy directly to the site of the injury and keeping it in place long enough to be effective are ongoing challenges. Even cardiac patches, which can be positioned directly over the site of the injury, have drawbacks in that they require invasive surgical methods for placement. ....

United States , Joe Rossi , Randallb Terry Jr , Thomas Caranasos , Nature Communications , American Heart Association , Hill Joint Department Of Biomedical Engineering , Department Of Molecular Biomedical Sciences , University Of North Carolina At Chapel Hill , National Institutes Of Health , Carolina State University , North Carolina State University , North Carolina , Distinguished Professor , Regenerative Medicine , Molecular Biomedical Sciences , Chapel Hill Joint Department , Chapel Hill , National Institutes , American Heart , University Of North Carolina , Unc Chapel Hill , Clinical Trial , Cell Therapy , Heart Attack , ஒன்றுபட்டது மாநிலங்களில் ,